Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QBTS vs GSK✓SelectedUSD · GSKQBTS vs GSK performance historyLatest closeAs of-10.81%11/20
Stock and ETF performance explorer

QBTS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-35.8%
GSK return
+63.2%
Excess return
-99.0%
Maximum drawdown
-96.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-10.8%-0.1%-10.7%-10.8%
7D-31.8%-5.3%-26.5%-31.5%
30D-46.1%-3.7%-42.5%-45.9%
3M-65.3%-7.3%-58.1%-65.1%
6M-66.2%-4.2%-62.0%-66.1%
YTD-75.1%+0.9%-75.9%-75.2%
1Y-68.2%+7.3%-75.5%-68.7%
3Y+644.3%+52.7%+591.6%+604.7%
5Y-33.8%+40.1%-73.9%-34.5%
All-35.8%+63.2%-99.0%-35.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling